| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 01/25/2007 | US20070020676 Method for manufacturing hydrogel biochip by using star-like polyethylene glycol derivative having epoxy group |
| 01/25/2007 | US20070020675 Modulation of endothelial lipase expression |
| 01/25/2007 | US20070020673 Model of autoimmune disease and methods for identifying agents against autoimmune disease |
| 01/25/2007 | US20070020663 Reaction monitoring systems |
| 01/25/2007 | US20070020661 for determining the presence of Cryptosporidium organisms in a test sample |
| 01/25/2007 | US20070020653 DNA polymerase |
| 01/25/2007 | US20070020652 Methods and compositions for RNA interference |
| 01/25/2007 | US20070020651 Compositions and methods for the inference of pigmentation traits |
| 01/25/2007 | US20070020635 Nucleotides for prevention and treatment of bacterial and fungal pathologies |
| 01/25/2007 | US20070020634 Polynucleotide sequence transcribed from a complementary polynucleotide sequence thereof; glutamyl O-tRNA suppresses in the presence of a tRNA synthetase (RS) selected from Archaeoglobus fulgidus, Methanosarcina mazei synthetase, Methanobacterium thermoautotrophicum, and Pyrococcus horikoshii synthetase |
| 01/25/2007 | US20070020632 Method for selective inhibition of human n-myc gene in n-myc expressing tumors through antisense and antigen peptido-nucleic acids (pna) |
| 01/25/2007 | US20070020625 Sequence of the photorhabdus luminescens strain tt01 genome and uses |
| 01/25/2007 | US20070020624 Nucleic acid and amino acid sequences relating to Pseudomonas aeruginosa for diagnostics and therapeutics |
| 01/25/2007 | US20070020622 DNA Polymerases and mutants thereof |
| 01/25/2007 | US20070020617 Gel microdrops in genetic analysis |
| 01/25/2007 | US20070020287 Virulence genes of M.marinum and M. tuberculosis |
| 01/25/2007 | US20070020286 Recombinant constructs of Borrelia burgdorferi |
| 01/25/2007 | US20070020285 prophylactic and therapeutic vaccination directed against the hepatitis C virus |
| 01/25/2007 | US20070020277 Human Oncogene Induced Secreted Protein I |
| 01/25/2007 | US20070020275 Nucleic acid sequences of hyperplasia and tumours of the thyroid |
| 01/25/2007 | US20070020270 Human serpin polypeptides |
| 01/25/2007 | US20070020268 Treatment of inflammatory bowel disease with ifn-gamma inhibitors |
| 01/25/2007 | US20070020260 Glycoprotein compositions |
| 01/25/2007 | US20070020259 Genetic engineered, chimera and human monoclonal antibodies that bind to lymphocytes CD antigens, used for diagnosis and prohylaxis of cancer and autoimmune diseases |
| 01/25/2007 | US20070020248 Process for biological tissue |
| 01/25/2007 | US20070020240 Defined dose therapeutic phage |
| 01/25/2007 | US20070020238 Method of targeted gene delivery using viral vectors |
| 01/25/2007 | US20070020237 Glucose inducible insulin expression and methods of treating diabetes |
| 01/25/2007 | US20070020236 Defective sindbis viral vectors |
| 01/25/2007 | DE10241553B4 Genetische Varianten im Gen TIMP-2 als ätiologische Faktoren verschiedener Erkrankungen Genetic variants in the gene TIMP-2 as etiological factors of various diseases |
| 01/25/2007 | CA2854576A1 Human anti-b7rp1 neutralizing antibodies |
| 01/25/2007 | CA2782619A1 Compositions and methods relating to orthogonal ribosome mrna pairs |
| 01/25/2007 | CA2658491A1 Membrane-translocating peptides |
| 01/25/2007 | CA2627081A1 Double-stranded rna stabilized in planta |
| 01/25/2007 | CA2617052A1 Protein extracted from plants of the genus lupinus or produced in recombinant form, nucleotide sequence encoding it and its use in animal nutrition, as a plant growth promoter andin the fight against pathogenic fungi |
| 01/25/2007 | CA2616258A1 Non-human animal model for cardiovascular disease characterized by a disrupted fibulin-4 gene |
| 01/25/2007 | CA2616256A1 Genetically modified antibody composition |
| 01/25/2007 | CA2616252A1 Oligonucleotide library encoding randomised peptides |
| 01/25/2007 | CA2616092A1 Novel carbosilane dendrimers, preparation method thereof and use of same |
| 01/25/2007 | CA2616021A1 Methods to express recombinant proteins from lentiviral vectors |
| 01/25/2007 | CA2615949A1 Modification of flavonoid biosynthesis in plants |
| 01/25/2007 | CA2615943A1 Yield increase in plants overexpressing the shsrp genes |
| 01/25/2007 | CA2615902A1 Delta 6 desaturase from thraustochytrid & its uses thereof |
| 01/25/2007 | CA2615797A1 Modified frt recombination sites and methods of use |
| 01/25/2007 | CA2615603A1 Biological materials and uses thereof |
| 01/25/2007 | CA2615578A1 Polypeptides having an activity in the mtbe degradation path and uses thereof |
| 01/25/2007 | CA2615562A1 Glycosylated il-7, preparation and uses |
| 01/25/2007 | CA2615468A1 Chimeric empty viral-like particles derived from the infectious bursal disease virus (ibdv), process for their production and applications |
| 01/25/2007 | CA2615458A1 Yield increase in plants overexpressing the mtp genes |
| 01/25/2007 | CA2615218A1 Mucosal or enteral administration of biologically active macromolecules |
| 01/25/2007 | CA2615151A1 Dna binding protein-polymerase chimeras |
| 01/25/2007 | CA2614972A1 Human anti-b7rp1 neutralizing antibodies |
| 01/25/2007 | CA2614955A1 Yield increase in plants overexpressing the hsrp genes |
| 01/25/2007 | CA2614567A1 Heterodimeric four helix bundle cytokines |
| 01/25/2007 | CA2614333A1 Yield increase in plants overexpressing the accdp genes |
| 01/25/2007 | CA2610237A1 Identification of a novel bitter taste receptor t2r76 that specifically responds to brucine and prop bitter ligands |
| 01/25/2007 | CA2604917A1 Recombinant yeasts for synthesizing epoxide hydrolases |
| 01/25/2007 | CA2578613A1 Binding domain fusion proteins |
| 01/25/2007 | CA2551906A1 Methods and reagents for detecting target nucleic acids |
| 01/24/2007 | EP1746421A2 Diagnostic and therapeutic application of antibodies against the urokinase receptor |
| 01/24/2007 | EP1746165A1 Scalable fermentation process |
| 01/24/2007 | EP1746163A1 Overexpression of soluble starch synthase II in plants |
| 01/24/2007 | EP1746162A2 Expression vectors encoding bispecific fusion proteins and methods of producing biologically active bispecific fusion proteins in a mammalian cell |
| 01/24/2007 | EP1746161A1 Glycosylated IL-7, preparation and uses |
| 01/24/2007 | EP1746160A2 Hepatocyte growth factor receptor antagonists and uses thereof |
| 01/24/2007 | EP1746159A2 Immunostimulatory nucleic acid molecules |
| 01/24/2007 | EP1746158A1 Micro-reactor for testing, genetic testing apparatus, and genetic testing method |
| 01/24/2007 | EP1746157A1 Method of proliferating plasma cell |
| 01/24/2007 | EP1746156A1 Probe and primer for tubercle bacillus detection, and method of detecting human tubercle bacillus therewith |
| 01/24/2007 | EP1746107A2 Antibody variants and fragments thereof |
| 01/24/2007 | EP1746106A2 Use of TACI as an anti-tumor agent |
| 01/24/2007 | EP1746105A2 Human 5-HT7 receptor promoter sequence |
| 01/24/2007 | EP1746102A1 Parechovirus, vaccines, medicaments and diagnostic kits |
| 01/24/2007 | EP1745801A1 Method of inhibiting telomerase activity and inhibitor |
| 01/24/2007 | EP1745799A2 Compositions and methods of treating tumors |
| 01/24/2007 | EP1745295A2 Methods, compositions and compound assays for inhibiting amyloid-beta protein production |
| 01/24/2007 | EP1745155A2 Multiplexed detection of biological agents |
| 01/24/2007 | EP1745153A2 Processing polynucleotide-containing samples |
| 01/24/2007 | EP1745148A1 A method for identifying activators of gene transcription |
| 01/24/2007 | EP1745132A1 Methods for high efficiency transformation and regeneration of plant suspension cultures |
| 01/24/2007 | EP1745131A2 METHOD TO INDUCE RNAi IN PROKARYOTIC ORGANISMS |
| 01/24/2007 | EP1745129A2 Canine pancreatic lipse |
| 01/24/2007 | EP1745128A2 PORCINE FORSSMAN SYNTHETASE PROTEIN, cDNA, GENOMIC ORGANIZATION, AND REGULATORY REGION |
| 01/24/2007 | EP1745123A1 Cholesterol-producing yeast strains and uses thereof |
| 01/24/2007 | EP1745074A2 Methods and compositions for enhancing cell adhesion properties |
| 01/24/2007 | EP1745072A2 Method for producing soluble mhc proteins |
| 01/24/2007 | EP1745068A2 Recombinant calf-chymosin and a process for producing the same |
| 01/24/2007 | EP1745066A2 Combinatorial protein library screening by periplasmic expression |
| 01/24/2007 | EP1745065A1 Antimicrobial polypeptides |
| 01/24/2007 | EP1745061A1 Novel amphiphilic compounds, preparation method thereof and applications of same |
| 01/24/2007 | EP1744788A2 Combinatorial methods and compositions for treatment of melanoma |
| 01/24/2007 | EP1744620A2 Novel gene disruptions, compositions and methods relating thereto |
| 01/24/2007 | EP1744619A2 Mutant receptors and their use in a nuclear receptor-based inducible gene expression system |
| 01/24/2007 | EP1530641B1 Dna expression construct for multiple gene expression |
| 01/24/2007 | EP1481007B1 Spheron components useful in determining compounds capable of treating symptoms of alzheimer's disease, treatments and animal models produced therefrom |
| 01/24/2007 | EP1438394B1 Pig mast cell cultures and uses thereof |
| 01/24/2007 | EP1383795B1 A recombinant newcastle disease virus nucleoprotein mutant as a marker vaccine |
| 01/24/2007 | EP1370694B1 Detection of methicillin-resistant staphylococcus aureus (mrsa) |
| 01/24/2007 | EP1356124B1 Circulating epstein-barr virus dna in the serum of patients with gastric carcinoma |
| 01/24/2007 | EP1337665B1 Immobilization of biopolymers to aminated substrates by direct adsorption |